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General Features of Viral Attachment
The initial step in viral infection is the attachment of the virus to
the host cell. The nature of this attachment and the necessary requirements
for the attachment have been the subject of many studies. Host range determi-
nations of various viruses were probably the first studies characterizing the
cellular specificity of viral attachment. Through these studies, it was
found that most viruses possessed a narrow host range and could only infect
cells from certain species of animals. For example, murine leukemia virus,
a retrovirus, can only infect murine tissues or cell lines (38) and, like-
wise, poliovirus will usually only infect primate tissue (48). There are
other viruses, like vesicular stomatitis virus (VSV), that have a relatively
broad host range. VSV will commonly infect bovine and equine species and
most established cell lines except non-stimulated T-cells and domestic
rabbit kidney and cornea cells (25, 104, 133). Because most viruses have
discrete host ranges, specific interactions must occur between a susceptible
cell and the infecting virus that do not occur with a resistant cell. At
first, the specific interaction between virus and host cell was believed to
only involve the process of viral attachment but further studies showed
viral penetration, uncoating, replication, assembly, and release might also
be limiting stages for viral infection (127). Since viral attachment is
the initial interaction of a virus with a cell, it is of particular interest
in the study of the infectious process.
The manner by which viruses attach to the surface of susceptible host
cells is not specifically known. It has been suggested that the interaction
of specific host-virus receptors could explain the specificity and physical
features of viral attachment. Essentially, a viral component functions as
the viral receptor which directly interacts with a cell surface moeity (cell
receptor). This interaction must be strong enough to maintain the virion
at the cell surface to allow penetration of the virus into the cell. Specific
proteins or glycoproteins of viruses have been shown to function as viral
components of attachment (80). Unlike bacteriophages, most animal viruses
do not have structural components that can easily be identified with the
process of viral attachment. The presence of virion fibers, which share
functional receptor properties with bacteriophages, appears to be restricted
to the members of the adenovirus group. In addition to the difficulty in
identifying viral components associated with attachment, identification of
the cellular receptor also has been difficult due to the large number of
proteins and glycoproteins on the surface of the eukaryotic cell. In some
cases, erythrocytes, which have relatively simple cell surfaces, have been
used to identify the cellular receptors for myxoviruses and adenoviruses
(80, 110).
The kinetics of virus attachment have been analyzed for numerous animal
viruses. In kinetic experiments, quantitation of virus binding has been
commonly determined by three methods: infectious assays, hemagglutination
assays, or measurements of the attachment of radiolabeled virions (135).
Most often, the amount of virus which bound to host cells was determined
by calculating the difference between the amount of virus initially
introduced to a cell population and the virus which failed to bind. The
quantities of virus initially added and that which failed to attach were
determined by quantitating infectious particles or hemagglutination units
by the plaque assay or hemagglutination assay, respectively. The use of
radiolabeled virions, developed more recently, provides a more direct and
accurate measurement of virion attachment. Unlike the plaque assay method,
which is limited to infectious particles and the hemagglutination assay that
is quite insensitive, the methods using radiolabeled virions measure
attachment of total physical particles and the technique is very sensitive.
The number of viruses which bind per cell or the number of cellular
receptors per cell has been determined for various virus-cell systems. The
maximum number of infectious coxsackievirus B3 that bound to HeLa cells was
found to be 200-300 plaque forming units per cell. This quantity of infectious
5
virus was equivalent to approximately 1 X 10 physical particles per cell (27).
Similarly, saturating levels of rhinovirus attached to HeLa cells have been
4 41-2 X 10 virion particles per cell (80) and approximately 1 X 10 receptor
sites per HeLa cell were estimated for adenovirus type 2 (112). Approximately
40.3-1 X 10 poliovirus particles attach per HeLa cell while 10-100 times
that amount binds to human fibroblasts (80, 88). In the case of poliovirus,
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the area covered by 10 picornavirus particles is only 1% of the surface
of the cell membrane (79). In all cases where saturation has been reached,
the saturation was independent of cell surface space and not a result of
spatial limitations. Contrary to the viruses previously mentioned, the
binding of some viruses, paramyxoviruses and myxoviruses (80), is not
saturable on their host cell which may be a reflection of the nature of the
cellular receptor. The cellular receptor for myxoviruses or paramyxoviruses
could possibly be a cellular component which is very abundant on the cell
surface or the cellular receptor for the virus may be a specific moiety,
i.e. carbohydrate, which is common to a large number of cell surface proteins.
Another possible explanation for being unable to saturate viral attachment
is myxoviruses and paramyxoviruses may have a number of binding sites on the
cell that are both specific and nonspecific.
The rate of virion attachment depends on the concentration of cell
surface receptors (i.e. the number of cells per milliliter). The efficiency
of attachment cf virions which collide with a cell is very low and the binding
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of virus will follow first order kinetics if less than saturating levels of
receptors were used (80). Various physiological factors such as pH, tempera-
ture, presence of divalent cations, and ionic strength of the binding
environment also effect the rate of attachment of virions to host cell.
The pH optima for binding of virions has been determined for many
virus-cell systems. Adenovirus and myxoviruses bind erythrocytes optimally
in a broad pH range from pH 5.5 to 8.7 (55,102). However, echovirus type 7
optimally attaches to erythrocyte membranes in a narrow range between pH 5
and 6 (108), and coxsackievirus B4 optimally attaches to HeLa cells between
pH 3 and 3.5 (26).
Myxoviruses (1), polyoma virus (24), equine rhinovirus (79), and cardio-
viruses (mengo, mengo encephalomyocarditis, Col SK, or encephalomyocarditis
viruses) have been shown to attach rapidly to host cells and the attachment
is not temperature sensitive (51, 64, 76). However, the attachment of most
other viruses is less efficient at low temperatures. Coxsackievirus B,
arboviruses, and adenovirus type 2 show a temperature dependency in their
rate of attachment (80, 107). The binding of poliovirus type 1 to mono-
layers of HeLa cells showed a 10-fold reduction in rate of binding at 1°C
relative to 37 C (49). Lonberg-Holm and Korant (79), also found poliovirus
type 1 and 2, as well as rhinovirus type 2 and 14, to have a rate of attach-
ment to suspended HeLa cells which increased by a factor of 2-3 times per
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10 C increase in a temperature range of 10 -37 C. The decreased rates of
attachment at lower temperatures was apparently not based on either the
decreased collision frequency between virus and suspended cell or an increase
in viscosity of the suspension media (80). Allison and Valentine (1)
developed an equation which corrects for the effect of temperature on the
maximum collision frequency of the virus and cell. However, the observed
temperature dependent decrease in rate of attachment mentioned was much
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greater than what was predicted by the Allison and Valentine equation (80).
The temperature sensitivity of attachment may be a reflection of a cellular
metabolic step or a conformational change in either virions or the cell
membrane which is required for a firm virus-cell complex to form.
The presence of divalent cations during viral attachment may infleunce
the rate of attachment. Unfortunately, the manner in which most of the
experiments were conducted do not provide definite conclusions as to the
role that divalent cations may have for attachment. For example, Bachtold
et aj_. (3) reported that poliovirus attachment was enhanced by magnesium
and calcium but the monkey cells used had been trypsinized and trypsin has
been shown to alter the number and characteristics of cellular receptors (80).
Other studies with nontrypsinized cells indicated divalent cations were not
required for attachment of poliovirus (49, 134). Many investigators have
shown that treatment of cells with sodium ethylene-diamine tetraacetate
(EDTA) inhibited binding of coxsackievirus and human rhinovirus (79, 84).
EDTA will chelate divalent cations from the surface of the cell but it is
possible that such treatment may have denatured or altered the proteins of
the cell membrane. If, in fact, divalent cations enhance the attachment of
certain viruses, it would provide a reasonable mechanism by which initial
binding occurs. The positively charged ions could mediate between the
negatively charged cell surface and negatively charged virion. It would
provide a charge balance which could, therefore, allow the virus to interact
with the cell electrostatically and to eventually promote a stronger attach-
ment that allows penetration of the virion.
The Viral Components Involved in Attachment
For many viruses, the various proteins which compose the virion have
been characterized and in some cases, specific functions associated with
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viral replication, have been attributed to particular viral proteins. In
particular, such studies have determined that one or two structural proteins
of the virus function as the viral component which directly interacts with
the host cell surface during attachment.
Influenza virus, a well characterized RNA enveloped virus, has been
extensively used as a model for studying the stages of viral attachment (80).
Two antigenically distinct proteins of influenza virus apparently influence
virion attachment. Both are envelope glycoproteins which protrude from the
virion surface but each have a different and specific function in binding
(143, 147). One protein, the hemagglutinin, is responsible for viral
hemagglutination of erythrocytes and viral attachment to susceptible host
cells (55). Antibody directed against the hemagglutinin prevents
hemagglutination, virion attachment, and neutralizes viral infection (80).
The second glycoprotein associated with the host-virus interaction is the
viral neuraminidase. This enzyme is responsible for the receptor destroying
activity of the virus which results in the hydrolysis of the host cell
surface receptor glycoprotein and leads to the elution of the virus from
host cells or erythrocytes (55). However, it is not known what, if any,
role the neuraminidase plays in the infectious disease process.
Adenoviruses are non-enveloped DNA viruses which have icosahedral
symmetry (111). At the 12 vertices of the icosahedron an elongated antenna-
like structure called the fiber can be seen projecting from the cell (106).
The fiber has been identified as the attachment structure for adenovirus
particles (121). Purified fiber, added in excess to HeLa cells, can prevent
the attachment of intact adenovirus. Likewise, an excess of virions prevented
fiber molecules from binding to cells (52, 112). Antibody directed against
the fiber inhibited virion attachment as well as the fiber attachment (55).
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Between 10 -10 fiber moecules were found to bind per HeLa cell. This
quantity is 10-100 times greater than the number of intact virions would
bind per HeLa cell (112). Since the fiber competes with the virion receptor,
the numerical difference suggests the fiber reaches cellular receptors not
available to the large virion or more than one fiber can bind per virion.
The viral receptors identified for enveloped viruses largely are glyco-
proteins which are constituents of the viral envelope. . For example, murine
leukemia virions possess an envelope glycoprotein (gp71) which has the
ability to bind to host cell surfaces (30). Likewise, the only glycoprotein
of VSV is associated with viral attachment (18, 19). Glycoproteins of
arboviruses and paramyxoviruses also have been designated as the viral com-
ponent for attachment (12, 129). For non-enveloped viruses, the identifica-
tion of the viral receptor material has not been as successful. One protein
of poliovirus, VP4 (6,000 daltons), is suspected to function as the viral
receptor (14, 80, 109) although it is not clear whether the VP4 protein is
the only viral component responsible for attachment. Bolen and Consigli
have investigated the specific and nonspecific adsorption of polyoma virus
to mouse kidney cells (11). Their most recent studies have suggested that
in polyoma virus, a subspecies of VP1 may be responsible for viral attach-
ment and hemagglutination. They also have preliminary evidence that the
viral component for hemagglutination and viral infection may be two
separate subspecies of VP1 (Bolen, personal communication).
Cellular Receptors Involved in Attachment of Viruses
Due to the nature and complexity of the host cell surface, the identifi-
cation of host cell receptors has only been studied in a few virus-host
cell systems. Although a number of studies have investigated the viral
aspects of attachment, little is presently known of the cellular involvement
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in the attachment process. This is possibly due to the present lack of
suitable techniques to identify, isolate, and chemically characterize surface
membrane protein(s) which interact with a virus. Despite the complexity of
identifying the cellular receptor, the cellular receptor for those viruses
which hemagglutinate erythrocytes, e.g. myxoviruses, adenoviruses, and
arboviruses, have been characterized fairly well due to the simplistic
nature of the surfaces of red blood cells (55). For those non-hemagglutinating
viruses, however, only indirect indications of the composition of the cell
proteins associated with viral binding is available (80).
The identification of the viral receptor of erythrocytes that bind
myxoviruses was one of the early monumental discoveries in virology. It
first began when Hirst et al_. (46) discovered that influenza viruses could
hemagglutinate red blood cells. Fowl erythrocytes treated with neuraminidase
were shown to be unable to bind the virion and this observation suggested
that sialic acid of a glycoprotein on the cell surface medidated viral attach-
ment (57). It was soon found that glycoproteins containing sialic acid,
which were purified from serum or respiratory fluid, bound strongly to the
virion and prevented the virion from binding to the host cell (55). A
protein, to which influenza was shown to selectively attach, was extracted
from erythrocytes with 50% hot phenol (68) or with lithium diiodosalicylate
and 50% hot phenol (81). Chemical analysis of the extracted material showed
the receptor to be a sialoglycoprotein with an apparent molecular weight of
55,000 daltons (54, 55, 68). This sialoglycoprotein contained the majority
of the N-acetylneuramic acid of the erythrocyte membrane and the sialic
acid was attached at the terminal end of the oligosaccharide (23, 29, 145).
Interestingly, this cellular receptor also contained the determinants for
the M and N blood groups (54, 68).
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The discovery and characterization of the influenza cellular receptor
explained earlier studies on the kinetics of influenza binding, i.e. the
fairly broad host range of myxovi ruses could be a reflection of the abundance
of sialic acid in most cells (125). The temperature independence of binding
by myxoviruses has also been attributed to the virus binding to the sialic
acid proteins of the cell (80). The sufficient quantity of neuramic acid on
the cell surface proteins can also explain why viral binding was never found
to be totally saturable.
A detailed mechanism of attachment for myxoviruses has been proposed.
Some ionizable amino group of the viral hemagglutinin, as indicated by the
pH dependency for attachment (55, 102), electrostatically interacts with the
terminal sialic acid of the glycoprotein identified as the cell receptor (80).
This initial interaction would facilitate a stronger interaction between
the hemagglutinin and the peptide portion of the cellular glycoprotein (145)
which would then lead to the uptake (28) of the virion into the cytoplasm.
Since the neuraminidase does not enhance the penetration of the virion into
the cell (55), it may act as a protective mechanism for the virus. If the
virus attached to a resistant cell and was not immediately engulfed into
the cell, this would allow time for the viral neuraminidase to cleave the
cellular receptor. This action would prevent the virus from entering an
unfavorable environment and might allow the virus to attach to a susceptible
host cell. Evidence also indicates that this reversible mechanism of viral
attachment may be employed by paramyxoviruses attaching to their host cells
(56, 128).
The identification of a cellular receptor for adenovirus has been
accomplished. Initial studies indicate that antibody directed against the
virion fiber protein prevented viral attachment and hemagglutination (80).
Treating HeLa and KB cells with the proteolytic enzyme, subtil in, prevented
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viral attachment, but the amount of virus binding was enhanced when cells
were treated with trypsin, chymotrypsin, or neuraminidase. These latter
enzymatic treatments probably increased the density of the cellular receptor
or exposed more receptors thus increasing the amount of virus binding (112),
although why subtil in destroys the cellular receptor is not known. The
cellular receptor for adenovirus has been solubilized and partially purified
by treating monkey erythrocytes with deoxycholate (101). The cellular
receptor (40,000 daltons) was shown not to interact with myxovi ruses and
was resistant to neuraminidase that suggested that the adenovirus receptor
differed from the cell surface glycoproteins which bind myxoviruses (82).
Based on the effects of pH and various chemicals on the viral attachment,
a model has also been proposed for the attachment of adenovirus to host cells.
The virion initially interacts with the host cell through one or two fiber
structures binding to the cellular receptor (112). It is believed that an
arginine molecule on the fiber protein forms a salt bond with the side chain
of an aspartate or glutamate molecule on the 40,000 dalton cellular receptor
(102). The virion attachment is strengthened by the apposition of additional
cell receptors which will bind to the other available fibers (110). The
virion is then engulfed by the plasma membrane and phagocytized into the
cytoplasm of the host cell (28).
More extensive investigations and more sophisticated techniques in
membrane biochemistry need to be developed in order to identify other viral
receptors in the complicated cell plasma membrane. In recent years, the
molecular biology of cell membranes has advanced to the point that many new
techniques can be applied to determining the nature of cellular receptors
for viruses. Recent advances in the study of murine leukemia virus (MuLV)
present an example of this. The MuLV system is interesting because of the
extremely limited host range of the virus. The virus will only infect
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murine derived cells and MuLV is capable of transforming murine thymic
cells (38). The cell surface binding sites, specific for the MuLV virions,
are found in high concentrations on the thymic lymphoma cells which are
induced by this virus, but are detectable at only low concentrations (if at
all) in several non-thymic leukemias or normal thymocyte cells (4, 83). To
better understand this phenomena, researchers have used purified preparations
of the viral receptor (the envelope glycoprotein, gp71 ) to study the initial
adsorption step in a productive viral infection (30, 39, 65, 144). Adding
radiolabeled gp71 to various cell lines, Weissman et a]_. , (144) also showed
that gp71 bound in high quantities to thymic lymphomas and in low quantities
to non-lymphomic cells. The binding of gp71 was rapid and approximately
5 X 10 molecules of gp71 saturated each cell within 25 minutes (30). Prior
addition of intact virus or unlabeled gp71 would inhibit the binding of
labeled gp71 to the cell surface (30, 39, 65). Attachment was temperature
dependent such that an increase in temperature would increase the quantity
of gp71 bound (30, 39, 65) and the maximum amount of binding occurred at a
pH of 6 to 7 (30). Also, the amount of binding of gp71 increased as the
concentration of calcium ions increased although magnesium or manganese did
not enhance the binding (30, 65). When the isolated gp71 was first reacted
with antiserum directed against the gp71 , no binding could be detected (30).
The characteristics of the binding of the isolated gp71 have suggested
the viral glycoprotein shares the cellular receptor with the intact virion.
This has allowed investigators to use gp71 as a probe for the cellular
receptor for MuLV. Cell membrane preparations were shown to have lost their
receptor activity after being treated with the proteolytic enzymes trypsin,
papain, and chymotrypsin. Neuraminidase or phospholipase A treatment did
not affect the ability of the membrane to bind gp71 , but binding was wery
sensitive to phospholipase C. The data suggested the cellular receptor
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component or complex contains a lipoprotein (65). Isolation of this lip-
protein has yet to be accomplished.
Investigations with other viruses and their cell surface receptors have
produced only indirect evidence as to the composition of the cell surface
receptor. For example, the cell receptor for poliovirus is believed to
contain a lipoprotein since poliovirus attachment is affected by treating
cellular membranes with ether or chloroform. However, poliovirus receptors
are also moderately sensitive to trypsin and chymotrypsin and preincubation
of cell membrane preparations with lipase did not reduce poliovirus binding
(49, 148). Treating host cells with formaldehyde, periodate, or disulfide
reducing agents did not affect viral attachment (47, 80). Since the use of
hydrolytic enzymes is, at best, limited as a means to identify and characterize
host cell surface receptors associated with virion adsorption, a considerable
amount of additional information remains to be obtained. An extensive review
of these rather indirect approaches to identify host receptors for virion
attachment has been written by Lonberg-Holm and Philipson (80).
General Properties of Vesicular Stomatitis Virus
Numerous structural and biochemical studies have been conducted on
vesicular stomatitis virus (VSV). Like other rhabdoviruses, VSV has a
bullet-shaped morphology with one end appearing flat and the other end
appearing as a tapered sphere. This cylindrical infectious virion is
typically 180 ± lOnm in length and 65 ± lOnm in diameter (22, 52, 75).
Another distinctive characteristic of these viruses is the presence of a
lipoprotein envelope which has peplomers, or spikes, uniformly spaced
throughout the entire surface of the virion. The protruding spikes are
lOnm long and appear to consist of hollow knobs at the end of short
stalks (20, 52). Wound inside the virion envelope is a helical ribonucleic
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acid-protein complex. Negatively-stained preparations of the virus observed
by electron microscopy often give the nucleoprotein complex a striated
appearance (100). As is found in other rhabdoviruses, the nucleic acid of
VSV is a single molecule of single-stranded RNA (5, 10). The overall
chemical composition of the Indiana serotype of VSV virions, which was used
in the following studies, includes 3% ribonucleic, acid, 64% protein,
13% carbohydrate, and 20% lipid (86).
The RNA genome, based on sedimentation analysis and direct measurements
of electron micrographs of isolated RNA, has a molecular weight of 3.8 X 106
daltons (15, 71, 115) and this size genome has the capacity to code for all
five viral proteins which compose the major proteins of the VSV virion (113).
As is found in myxoviruses and paramyxoviruses, the RNA strand is designated
as the negative strand because the RNA genome is anti polar to the viral
mRNA and, therefore, is unable to directly serve as a template for viral-
directed protein synthesis (5, 140). The VSV virion is composed of five
major proteins: the nucleocapsid (N) protein, the viral transcriptase (L),
the nonstructural (NS) protein, the matrix or membrane (M) protein, and
the glycoprotein (G) (98, 139, 140). Other minor proteins have been
detected by polyacrylamide gel electrophoresis but these proteins are not
consistently found in purified VSV (9, 66, 138).
The nucleocapsid of the VSV virion is composed of the viral RNA and
three proteins: N, L, and NS proteins. The N protein, which is tightly
bound to the nucleic acid, has a molecular weight of 52,000 daltons, and
constitutes 30% of the virion protein (10, 19, 21). Although no enzymatic
activity has been found to be associated with the N protein, the estimated
1,100 to 2,300 N protein molecules per virion provide a significant amount
of stability and resistance of the viral RNA to various degradative enzymes
(9, 10, 19). The L protein, also associated with the nucleocapsid complex,
16
appears to be the viral transcriptase (6, 33, 34). This protein has a
molecular weight of 190,000 daltons (L=large) and since there only are
approximately 60 copies per virion, it constitutes only 2.5% of the total
VSV virion protein (9, 10, 34). The third protein that is found associated
with the VSV nucleocapsid is the NS protein which has a molecular weight of
30,000 to 35,000 daltons (103, 118). At one time it was considered to be a
nonstructural protein since it is synthesized in relatively large quantities
in the infected host cell, although only small amounts could be detected in
the virion (67, 141). However, recent studies have shown the NS protein to
be necessary for the L-protein (transcriptase) to function (34, 63). The
possibility that the NS protein may modulate transcriptase activity has been
emphasized by the observations that this minor component (2.3% of the virion
protein) can exist in either a phosphorylated or a nonphosphorylated state
(10, 95, 130).
The viral envelope, which surrounds the nucleocapsid of the virion, con-
tains a lipid bilayer and the two remaining viral proteins: the glycoprotein
(G: 69,000 MW) and the membrane or matrix protein (M: 29,000 MW) (19, 137).
The G and M proteins compose 35% and 29%, respectively, of the total viral
protein (10). The protein matrix on the intracellular side of the envelope
is predominantly composed of the M protein (32). The G protein, the only
glycoprotein of the VSV virion, is found inserted within the lipid bilayer
and can be visualized as a peplomer or spike protruding from the surface
of the virions with approximately 500 of these proteins per virion (19, 52,
85). Further evidence, which will be discussed later, indicates the G protein
is the viral component that initially interacts with the host cell surface
receptor. Although the VSV RNA and proteins are specified by the viral
genome, the lipids in the envelope are derived from the host cell (86).
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VSV possesses a very extensive host range, as reviewed by Bishop and
Smith (10). Those cells which can be infected by VSV must share some common
or similar receptor for the virus to attach and propagate. Common cell lines
used to study VSV have been L-cells, baby hamster kidney cells and HeLa cells.
Even cells of drosophila and mosquitoes can support the replication of VSV
(124). Only a few cell lines, such as non-stimulated T-cells and domestic
rabbit kidney and cornea cells, will not allow VSV to undergo a productive
infection (25, 104, 133).
The infection and maturation process of VSV is similar to other
enveloped viruses. The initial stage of infection involves the attachment
of the virion to the host cell surface (10). There is evidence for entry of
the VSV virion both by fusion of the viral membrane envelope with the cell
surface membrane (44) and by phagocytosis of the intact virus particle (126).
Although, biochemical evidence supports the mode of entry associated with
membrane fusion, evidence is still lacking as to whether one mode of entry
is particularly advantageous than the other (45).
Following the entry of the intact virion or the nucleocapsid alone,
the viral components are synthesized with the aid of the protein synthetic
machinery of the host cell. Because the RNA genome is anti polar and is
incapable of acting as mRNA, transcription is a required step in the
initiation of viral replication. Four different size classes of mRNA (31S,
17S, 14. 5S, and 12S), that are transcribed from the viral genome, have been
isolated (60, 93, 94, 99). In vitro translation of the purified mRNA species
has demonstrated the 31 S mRNA codes for the L protein (91), the 17S mRNA
codes for the G protein, the 14. 5S codes for the N protein (13, 74), and
the 12S mRNA codes for both the NS and M proteins (13, 74, 116). The
mechanism of transcription and post-transcriptional processing of these
mRNAs has yet to be totally resolved. Current models propose that the
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RNA polymerase initiates transcription at the 3' terminus of the RNA template
genome and continuously moves toward the 5' end of the genome. A "processing
enzyme" (of unknown origin) would then recognize specific sequences in the
transcribed mRNA and cleave it into cistron-sized mRNAs. These cleaved mRNAs
would then be polyadenylated at the 3' end and capped and methylated at the
5' end (7). Some studies have presented evidence that would contradict this
proposed model. Hefti and Bishop (43) detected a small number of mRNAs which
have a specific unblocked sequence at the 5' end which could be a precursor
for the capped structures eventually isolated. Thus, in this situation,
each mRNA may be independently initiated. To date, the actual mechanism
of transcription of VSV mRNAs is not definitely known.
The process of replicating the negative strands of RNA is also not yet
known. A complementary strand (the positive strand) of full length must
be synthesized from a full length negative strand. Such a replicative
intermediate has been detected in infected cells but not in in vitro RNA
transcriptase assays (92). Since only monocistronic mRNAs, coding for
individual virus structural proteins were transcribed in vitro
, there must
be either an alternate pathway for the synthesis of the positive and comple-
mentary strand by the virion-associated polymerase, or a replicase activity
different from the RNA polymerase that is active in the in vitro synthesis
system (7).
While viral transcription is occurring in the infected host cell,
cellular metabolism is altered drastically by the presence of VSV resulting
in a suppression of macromolecular synthesis including proteins and RNA (98,
105, 141). Huang et a]_. (60), have demonstrated the breakdown of host
polyribosomes during the third hour of infection and the reformation of
a different population of smaller and virus-specific polysomes during the
fourth hour. Using these virus-specific polysomes investigators have shown
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that the viral proteins N, NS, L, and M are synthesized with no evidence
of post translation cleavage (73, 98, 141). In contrast to the other viral
polypeptides, the G protein has a relatively complex pattern of synthesis
and maturation. The G polypeptide is initially synthesized on polysomes
associated with the rough endoplasmic reticulum and is directly inserted
into the lipid bilayer where it is partially glycosylated by host glycosyl
transferases (13, 41, 90, 136). The immature glycoprotein then migrates
to the smooth endoplasmic reticulum of the Golgi apparatus where further
glycosylation occurs just prior to the insertion of the G protein into the
surface membrane (73).
The maturation and insertion of the G protein in the infected host cell
surface appears to play an important role in viral maturation and release.
Only after the G protein is inserted into the host membrane, can the M
protein bind stably to the intracellular side of the surface membrane (73).
If the G protein is not already inserted in the cell surface, the M protein
is found in a soluble fraction, not membrane associated, and viral maturation
is aborted (73). If the G protein is inserted into the cell surface, the
VSV nucleocapsid with the RNA, N, L, and NS proteins, which have accumulated
in the cytoplasm, will then assemble at the modified host membrane. After
the assembly at the cell surface, the virus particle will be released by
budding from the plasma membrane thereby acquiring an envelope that includes
the host cell lipid bilayer (53).
During the infection of cells with VSV, two types of particles are
most often produced: the infectious B-type particles and the defective-
interfering T-type particles. The B-type particles are complete in all
viral components, have the typical bullet-shpae morphology, and are
infectious (137). The T-type particles are identical to the B-type particle
in protein composition, however, T-type particles contain only a fraction of
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of the RNA which results in a particle with a spherical morphology (61, 100).
The T-type particles are defective because their RNA genome is incomplete
and, therefore, can only replicate in host cells infected with B-type
particles (119, 120, 131). Although the T-type particles are unable to
replicate alone, they have the ability to interfere with VSV replication when
present in the host cell at high concentrations (58). The mechanism by which
T-type particles interfere with VSV replication is not definitely known but
data suggests the T-type particles may interfere with viral RNA replication.
The RNA from the defective particles appear to actively compete with the
RNA from B-type particles for the limited number of the viral-specific RNA
polymerase molecules thus reducing the number of complete RNA genomes and
increasing the relative proportion of T-type particles (59).
Chemical Composition and Function of the Glycoprotein of VSV
The chemical and physical structure of the glycoprotein (G) of VSV has
been studied by several investigators. Biochemical studies of the G protein
have been aided by various isolation techniques which readily separate the
G protein from the other viral proteins (9, 42, 70, 117, 132). Two
oligosaccharide chains per glycoprotein molecule have been detected by several
groups (35, 37, 117), although different numbers of oligosaccharide chains
have been reported (96). Each oligosaccharide chain has a molecular weight
of 3000 - 3400 da! tons which represents approximately 5% of the glycoprotein
by weight (35, 37, 96, 117). These oligosaccharides have been shown to be
complex structures containing fucose, mannose, galactose, N-acetlyglucosamine,
N-acetylgalactosamine and sialic acid (35, 36, 87). The carbohydrate moiety
has been shown to be linked to the amide nitrogen of asparagine in the peptide
portion of the G protein (114). The VSV glycoprotein contains a core
structure which is similar to and common to other known asparagine-1 inked
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oligosaccharides of other glycoproteins such as those isolated from chicken
egg albumin or ^-amylase from Aspergillus oryzae (77). The terminal sugar
of the carbohydrate chain is neuramic acid and can be easily removed by
treating the virion with neuraminidase (122, 123).
Investigators who have studied the carbohydrate composition of the
G protein have disagreed on the actual number of specific carbohydrate
residues per glycoprotein molecule (35, 87, 114). The variance in the number
of sugar residues may, however, be a reflection of the host's influence on
glycosylation of the G protein molecule as the carbohydrate composition
depended on the host cell lines. This may be reasonable since the virus
itself does not contain glycosyl transferases and, therefore, must rely on
the glycosyl transferases of the host to add the oligosaccharide chains
associated with the peptide of the G protein (10). Etchison and Holland (36)
compared the G protein of virions which had been grown in four different cell
lines. Both qualitative and quantitative differences occurred in the carbo-
hydrate composition of the G protein. Approaching the question differently,
Bruge and Huang (16) showed that when two unrelated envelope viruses Sindbis
virus and VSV when grown in the same cell line, the glycoproteins of each
virus contain the same carbohydrate composition. They also went on to show
the carbohydrate composition of the progeny virions was different from the
sugar composition of the original viruses used to infect the cells. These
findings indicate that the host cell can influence the glycosylation and
final chemical composition of the G protein molecules.
The G protein of VSV is the constituent of the peplomers or spikes
that can be seen protruding from the virion (22). When VSV virions are
exposed to proteolytic enzymes such as trypsin, pronase, chymotrypsin, and
bromelain, the G protein was selectively removed (17, 85). All that remains
of the G protein after enzymatic digestion is a non-glycosylated hydrophobic
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tail which is embedded in the virion envelope (97). Just recently, Katz
and Lodish (69), presented evidence that the G protein is found in a
transmembrane, asymetric orientation in the viral envelope with the carbo-
hydrate moiety extending outward from the surface and a small portion being
exposed on the cytoplasmic side of the envelope. Iodination of intact VSV
virions by methods used to locate the surface proteins of cells and other
viruses, e.g. chloramine T or lactoperoxidase procedures, disclosed that
the G protein was the only viral protein significantly labeled and further
substantiated the outer location of the G protein (89, 142).
During the infectious cycle of VSV the G protein functions as the
viral component which initially interacts with, and attaches to, the plasma
membrane of the susceptible cell. A loss of infectivity, often .0001% of
the original titer, is seen with VSV virions that are treated with trypsin
to remove the G protein (8). Temperature-sensitive mutants of VSV, belonging
to complementation group V, which are defective at elevated temperatures in
the synthesis or maturation of the G protein, are also incapable of infecting
cells unless they are co-infected with another envelope virus like avian
retroviruses (78). By comparing antiserum prepared against the VSV G protein
and other structural proteins, it was shown that only antiserum against the
G protein would neutralize viral infection (31, 70). All of these observa-
tions suggest that the G protein is the viral component that is involved
in attachment or adsorption of the virion to the host cell.
The G protein has also been shown to be responsible for the ability
of VSV to hemagglutinate goose erythrocytes (2). Hemagglutination of the
red blood cells can be blocked by neutralizing antibody which is directed
against the G protein (137). Also, isolated G protein is capable of
hemagglutinating goose erythrocytes at a pH of 6 and at 4°C (50, 85).
These hemagglutination studies also suggested that no neuraminidase was
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found associated with VSV virions, which is contrary to what is found in
influenza virus (72). When intact VSV virions are treated with y_. cholera
neuraminidase to remove the terminal neuramic acid of the G protein, a loss
of 99% in VSV infectivity and a similar decline of hemagglutination activity
are measured (122). VSV virions that were grown in A. albopictus mosquito
cells were found to lack sialic acid and were not able to efficiently infect
cells (124). Therefore, the presence of neuramic acid appears to be helpful
to the ability of the virus to interact with the cell.
Little information is available concerning the cellular receptor for
VSV attachment. One study where BHK-21 cells were treated with trypsin,
neuraminidase or DEAE-dextran showed that attachment of intact VSV was
increased (123). The enhancement in binding could be attributed to the
enzymatic removal of proteins that interfere with viral attachment and/or
increasing the relative density of the cell receptor which would allow
multivalent binding of the virus. By using the isolated G protein as a
probe, hopefully more information can be collected so this host-virus
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MANUSCRIPT: ISOLATION OF THE GLYCOPROTEIN
OF VESICULAR STOMATITIS VIRUS AND ITS
BINDING TO CELL SURFACES
11
SUMMARY
The glycoprotein (G) of vesicular stomatitis virus was radiolabeled,
extracted and purified to allow the study of its potential interaction with
host cell surfaces. Incubation of BHK-21 cells with the radiolabeled viral
glycoprotein resulted in a rapid attachment of the viral component to the
cell surface. The attachment was shown to be temperature dependent and
5
saturable in that approximately 3 X 10 molecules bound per cell. The
deletion of Mg or Ca from the incubation medium had little affect on
the glycoprotein binding. Treatment of the isolated G protein and intact
virions with neuraminidase did not significantly decrease their binding
to BHK-21 cells. Preincubation of cells with trypsin did not decrease the
attachment of VSV virions nor the binding of purified G protein. Treatment
of cells with phospholipase A or phospholipase C suggested that the binding
of the glycoprotein and the intact virion may have been dissimilar. Unlabeled
glycoprotein was shown to competitively inhibit binding of the labeled
molecules although the presence of intact virions did not inhibit attach-
ment of the G protein. Likewise, saturating amounts of the glycoprotein
did not decrease binding of vesicular stomatitis virus to BHK-21 cells.
These observations suggested that the isolated glycoprotein either bound
to cell surface components that were distinct from the virion receptor or
that the manner of the purified glycoprotein attachment was different than
the G protein still associated with the intact virion. Chemical cross-
linking and diagonal two-dimensional gel electrophoresis were used to
identify and to compare the cell surface components responsible for glyco-
protein and virion attachment.
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INTRODUCTION
The initial interaction between viruses and the host cell surface has
been the subject of numerous studies. In most cases, however, investigators
have focused on the physical and chemical properties of the viral components
that are responsible for virion attachment (Bose & Sagik, 1970; Lonberg-Holm
& Korant, 1972; Philipson & Lindberg, 1974). Until recently most studies
involving the host cell surface receptor complexes associated with virus
attachment have been limited to indirect examination by enzymatic analyses
and many have been restricted to erythrocyte surfaces. For instance, sialic
acid of a surface glycoprotein of erythrocytes was shown to mediate
influenza virus attachment (Kathan et al_. , 1961; Hoyle, 1968) and glycoproteins
that contain sialic acid, present in serum and respiratory fluid, were shown
to prevent virion attachment to susceptible cells (Howe & Lee, 1970). This
host cell surface glycoprotein contains most of the N-acetylneuramic acid
of the erythrocyte membrane (Cook et al_. , 1961; Dannon et. al_. , 1965) and
interestingly, also contains the determinants of the M and N blood group
substances ( Kathan et al_. , 1961; Howe et aJL , 1963).
A cell surface glycoprotein, devoid of sialic acid, has been isolated
and characterized as being responsible for the binding of adenovirus, type 7,
to susceptible cells (Neurath et al_. , 1970). More recently, a glycoprotein
(gp71) of murine leukemia virus has been used as a molecular probe to identify
the host cell component responsible for virion attachment. The binding
properties and requirements of the gp71 molecule were shown to be similar
to the intact virion (DeLarco & Todaro, 1976; Fowler et al_. , 1977). Further
studies of the cell surface component have suggested that the murine leukemia
virus binds to a lipoprotein (Kalyanaraman et a]_. , 1978).
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Vesicular stomatitis virus (VSV), a rhabdovirus that possesses an
unusually broad host range which includes established cell lines of
arthropod, avian, and mammalian species, has a sole glycoprotein (G) that
is responsible for virion attachment (Kelley et a]_. , 1972; Bishop et al
.
,
1975). Antiserum prepared against the glycoprotein neutralizes viral
infectivity while antibodies directed against other VSV structural proteins
do not inhibit viral infection (Kelley et al_. , 1972; Dietzschold et al
.
,
1974). Schloemer and Wagner (1975) found that the cellular receptor for
VSV was resistant to treatment with neuraminidase and trypsin. Beyond this,
little is known about the chemical nature of the cellular receptor for VSV
or the nature of the viral interaction with the host cell surface. However,
the characterization of the chemical and physical properties of the VSV-host
cell interaction may be fundamental to our understanding of the reasons why
this virus has such a broad host range. These studies were initiated to
determine if the isolated G protein of VSV could bind to cell surfaces and
if the nature of the G protein attachment was related to the interaction of
the cell with the intact VSV virion.
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METHODS
Cell culture . Baby hamster kidney cells (BHK-21), obtained from
International Scientific Industries, Cary, Illinois, were maintained as mono-
layer cultures by routine cell culture methods (Rabinowitz et al_. , 1976).
The BHK-21 cells were grown in Earle salts supplemented with 7% virus
-
screened fetal calf serum, 10% tryptose phosphate, 2mM glutamine, 1% non-
essential amino acids, 1% minimal essential medium vitamins, and penicillin
(1000 U/l), streptomycin (1 mg/1), fungizone (2.5 mg/1, and gentamycin
(20 mg/1) (Grand Island Biological Co.). BHK-21 cells were grown to
confluency in 32 oz. sterile glass bottles by incubation at 37 C in a
5% C0
2
~ 95% air atmosphere in a water-jacketed incubator.
Virus preparation and purification . The Indiana serotype of VSV was
added to monolayers of BHK-21 cells at a multiplicity of infection (M0I) of
0.1 plaque forming units (PFU) per cell and allowed to adsorb for 30 min
at 25°C. Culture media was added and whenever appropriate, 5 yCi/ml of
3 35
H-fucose and/or 5 yCi/ml of S-methionine (New England Nuclear Corp.)
were added. The infected cells were incubated at 37°C for 18-24 h. Mature
virions released into the medium were isolated by first removing cellular
debris by slow speed centrifugation (5,000 x g for 10 min). VSV virions
were then pelleted from the resulting supernatant fluid by ultracentrifugation
at 32,000 x g for 3 h at 4°C. The virus pellet was suspended in TEN buffer
(50mM Tris-HCl, lOOmM NaCl , 5mM EDTA, pH 7.4), briefly sonicated (Sonifier
Cell Disruptor, Model W140D, at a setting of 3 for 5-10 sec), and repelleted
at 136,000 x g for 1.5 h at 4
C
C. The final VSV pellet, containing both B
and T-type particles (Haung et al_. , 1966), was resuspended in either TEN
buffer or Hanks' balanced salt solution (HBSS) (Hanks S Wallace, 1949),
briefly sonicated, and stored at -90°C.
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Plaque and plaque reduction assays . Ten-fold serial dilutions of purified
VSV were prepared in HBSS and 0.1 ml was plated onto monolayers of BHK-21
cells cultured in six-well plates (35 X 10 mm, Linbro, Co.). After virus
was allowed to adsorb to cells for 30 min at 25°C, the monolayers were
overlayed with growth media supplemented with 0.37% agar (Difco Laboratories)
as a solidifying agent. All samples were plaqued in duplicate and plates
were incubated at 37°C for 24-48 h. After incubation, the agar medium was
removed and the plates were stained with crystal violet (Hughes et al_. , 1979).
Isolation and purification of G protein . The G protein was isolated by
a modification of a technique used by Hale et aj_. (1978). Nonidet P40 ((MP40),
Shell Oil Co.) was added to purified virions to a final concentration of 1%
(V/V) for 20 min at 25°C with occasional stirring. The nonsolubilized nucleo-
capsids were then separated from the solubilized envelope G and M proteins,
by pelleting the nucleocapsids through 20% sucrose at 136,000 x g for 90 min
at 4°C. The viral envelope proteins, which remained above the 20% sucrose,
were collected for analysis by SDS-PAGE and further purification. The M and
G protein were then separated on a Sephadex G-75 column (56 X 1.1 cm) using





pH 7.4) to elute the two proteins. The G protein eluted in the void
volume, while the M protein eluted in later fractions. The fractions con-
taining only the G protein were pooled and used to measure binding of the
VSV glycoprotein to BHK-21 cells.
SDS-polyacryl amide gel electrophoresis (SDS-PAGE) . Viral proteins of
VSV and various protein samples were analyzed by SDS-PAGE according to the
method described by Laemmli (1970). The sample proteins were electrophoresed
(2.5mA/gel) through a 3% polyacryl amide stacking gel (2 cm) and a 9%
polyacryl amide separating gel (10 cm). With radioactive samples, the
gels were frozen following electrophoresis and sliced into 1mm slices. The
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slices were mixed overnight in a NCS: scintillation cocktail mixture
(Hughes et a]_. , 1979) and the radioactivity was measured in a Packard
Tri-Carb liquid scintillation spectrometer, model 3320. Those gels which
contained unlabeled protein were stained following electrophoresis with
Coomassie brilliant blue and were scanned at 500nm using a Gilford
spectrophotometer (Model 250) with a linear transport module. Areas under
viral protein peaks were integrated using a Numonics electronic graphic
calculator. In all instances of gel electrophoresis, samples of bovine
serum albumin (MW 68,000 daltons), ovalbumin (MW 45,000 daltons), and
chymotrypsinogen (MW 25,000 daltons) were co-el ectrophoresed as molecular
weight standards to determine the molecular weights and identity of the viral
proteins.
Antiserum to G protein
. Isolated G protein, approximately 0.5-1.0 mg,
was added to complete Freund's adjuvant and injected subcutaneously into New
Zealand white rabbits. A booster injection containing incomplete Freund's
adjuvant was given every two weeks following the initial injection. Serum
was collected every two weeks and tested for the ability of the antiserum
to neutralize viral infection by plaque reduction assay. Serum with high
neutralizing titers were pooled and IgG immunoglobulins were purified as
previously described (Heide & Schwick, 1978; Fahey & Terry, 1978). Briefly,
the serum was precipitated repeatedly with sodium sulfate, the precipitate
was dissolved in 0.03M Tris-HCl-phosphate buffer (TP), pH 8.0 and was then
fractionated on a DEAE-cellulose column (80 X 2.5 cm) previously equilibrated
with the TP buffer. The IgG which elutes in the void volume was then con-
centrated in an Amicon ultrafiltration cell (Amicon Corp.) using a type PM-10
ultrafiltration membrane. In order to reduce non-specific reactions, purified
antiserum (0.1 mg) was absorbed for 30 min at 37°C with 1 X 107 BHK-21 cells
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prior to use. Neutralization titers of antiserum were determined by a plaque
reduction assay. Five-fold dilutions of antiserum were reacted with an
equal volume of VSV (1 X 10
8
PFU) for 30 min at 37°C and then plaqued on
BHK-21 monolayers as described above.
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Binding of G protein to BHK-21 cells . H-fucose and S-methionine-
labeled G protein, at the designated concentrations, was mixed with two volumes





pH 7.4) and one-third volume of 12.6mM CaCl
2
- The BHK-21 cells
were prepared for the binding studies by scraping the cell monolayers with a
rubber policeman, pelleting the cells by slow speed centrifugation and then
suspending them in HBSS. The labeled G protein was added to 7.5 X 10 -
1 X 10 cells for the binding assay. Following incubation, the cells were
pelleted and the supernatant discarded. Cells were washed twice with HBSS
and the final pellet was solubilized with IN NaOH. The solubilized cell
solution was dissolved in 3.5 ml of Biofluor scintillation cocktail (New
England Nuclear, Corp.) and 2 drops of IN acetic acid were added to each
vial and the radioactive incorporation determined in a Packard Scintillation
spectrometer. The number of G protein molecules which bound per cell was
calculated from the specific radioactivity of the G protein after a zero time
point as background was subtracted. The specific radioactivity of the
G protein preparation isolated from labeled VSV virions ranged from 4.3 to
5
8.7 X 10 CPM/mg protein. Protein concentrations were determined by
procedure of Lowry et al_. (1951) using bovine serum albumin as a protein
standard.
Enzymatic treatment of BHK-21 cells . Ten ml of a trypsin solution
(1:250) or 1 U of phospholipase C (Sigma Chem. Co.) were incubated with
7.5 X 10
6
BHK-21 cells for 30 min at 37°C. Five units of phospholipase A
(Sigma Chem. Co.) were added to 7.5 X 106 BHK-21 cells for 30 min at 25°C.
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After enzymatic treatment, cells were pelleted and washed 3 times with HBSS
prior to being used in a binding assay. Phospholipase C was suspended in
0.5mM phosphate buffer, pH 7.4 and phospholipase A was suspended in 0.22M
NaCl, 20mM CaCl
2
, and ImM EDTA, pH 7.5.
Neuraminidase treatment of virus and G protein . Approximately 5U of
V.. cholera neuraminidase (Cal Biochem-Behring Corp.) was incubated with
1 X 10
7
PFU of 35S-methionine-labeled VSV for 90 min at 37°C. Treated
virions were pelleted by ultracentrifugation, suspended in HBSS, and
infectivity was analyzed by plaque assay on BHK-21 cell monolayers. Approxi-
mately 8 g of labeled G protein was treated with 0.5U of neuraminidase
linked to agarose beads (Sigma Chem. Co.) at 37°C for 3 hours and the
enzyme beads were then removed by centrifugation. Attachment of enzyme
treated G protein and virions was evaluated and compared to G protein or
virions treated in the same manner but without neuraminidase.
Cross! inking G protein and VSV to cell surfaces . Saturating amounts
of labeled G protein (50 ug) or intact virions (M0I=100) were adsorbed to
6 X 10
7
BHK-21 cells for 30 min. Cells were washed and 6.0 mg of the
chemical crosslinker, dimethyl-3,3'-dithiobispropionimidate dihydrochloride
(DTBP, Pierce Chemical Co.), was added to cells for 30 min at 4°C according
to the procedure outlined by Takemoto et a]_. (1978). After incubation with
the crosslinker, cell membranes were isolated by treating crosslinked cells
with 1% NP40 for 15 min on ice, removing nuclei by centrifugation and
then diluting the supernatant, containing the solubilized cell membranes,
two-fold with the final buffer of Takemoto et aj_. (1978). A sufficient
quantity of purified IgG (0.2 mg) directed against the G protein and
preabsorbed with BHK-21 cells was incubated with the cell membrane fraction
for 30 min at 37°C and then placed at 4°C overnight. The resulting precipi-
tate was pelleted by centrifugation, suspended in sample buffer without
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mercaptoethanol (Kelly & Luttges, 1975) and labeled by the chloramine T
iodination method (Moore et a]_. , 1974). As a control, cells which were not
exposed to either G protein or VSV virions were crossl inked with DTBP, cell
membrane fractions were collected, reacted with antiserum and iodinated in
a similar manner.
Crosslinked species precipitated by the IgG were resolved by diagonal
two dimensional electrophoresis. Approximately 4X10 CPM of each sample
were electrophoresed (lOmA/gel) through a 3% acrylamide stacking gel and 9%
acrylamide separating gel in the absence of 2-mercaptoethanol . After
electrophoresis, sample tracks were cut out, placed horizontally above
another prepared polyacrylamide gel, and immobilized on the top of the slab
gel with 0.5% agarose, .38 M Tris-HCl (phi 8.8), and 0.5M mercaptoethanol to
cleave the crosslinked species and to allow their separation by electrophoresis
in the second dimension. Gels were initially electrophoresed at lOmA/gel
until the tracking dye approached the separating gel after which electro-
phoresis was continued at 30mA/gel . After electrophoresis, gels were
stained and fixed with 0.25% Coomassie blue in 50% methanol and 5% acetic
acid, dried by vacuum, and exposed to Kodak XRP-1 film for 1-2 days.
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RESULTS
Isolation and purification of the G protein
Initial studies were carried out to determine the protein and glyco-
protein composition of the purified VSV virions and the efficiency of NP40
in separating the virion envelope and nucleocapsid components. SDS-PAGE
analysis of complete VSV virions clearly separated the major structural
3
proteins; and virus previously labeled with H-fucose, which labels only
the viral glycoprotein (G), provided a convenient marker (Fig. 1). The
relative proportions of each protein in the intact virions and the
nucleocapsid and soluble membrane fractions following NP40 extraction were
determined by staining the gels with Coomassie brilliant blue, integrating
the areas under each viral peak and comparing the area to the total. The
protein composition of the virion was 3.2% L protein, 28.5% G protein,
33.7% N protein, and 34.1% M protein (Table 1). The NS protein, which
mormally constitutes only 1% to 2% of the viral protein (Bishop & Smith,
1977), could not be accurately quantitated because of the small amount
and the fact that it often migrates close to the N protein.
MP40 extraction provided an efficient method to separate the nucleocapsid
and envelope proteins of VSV. The nucleocapsid pellet contained 100% and
96% of the L protein and N protein, respectively. Approximately 75% of
the G protein was solubilized by treatment with NP40 and SDS-PAGE analysis
of this soluble fraction showed that only a trace of the major nucleocapsid
protein (N) was present (Table 1). The G and M proteins of the virion
envelope were separated by gel filtration on a Sephadex G-75 column as
described in the Methods section. SDS-PAGE analysis of the G protein
fraction, which eluted in the void volume, demonstrated that the preparation
was composed of over 97% G protein and contained less than 3% M and N (fig. 2).
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The purified G protein appeared to be intact since its migration by SDS-PAGE
was identical to the glycoprotein of intact virions. This purification
procedure allowed a recovery of 55% of the initial G protein of the VSV.
Binding of G protein to BHK-21 cells
In preliminary experiments we found that the purified radiolabeled
G protein of VSV bound tightly to BHK-21 cells. In order to optimize the
binding of the G protein to BHK-21 cells, we measured the effects of varying
the concentration of G protein, incubation temperature, time of incubation,
the composition of the binding medium, and cell concentration. When
increasing concentrations of G protein were incubated with 1 X 10 BHK-21
cells at 25°C, the amount of G protein bound was essentially maximal at
5.0 pg (Fig. 3). Increasing the concentration of G protein to over 15 ug
per reaction resulted in little additional binding. These kinetics suggested
that the binding reaction was saturable and that there were a definitive
number of average binding sites per cell (^ 2-3 X 10 ).
The kinetics of G protein binding to BHK-21 cells was shown to be
relatively rapid in that 57% and 78% of the binding reaction was completed
within 5 min of incubation at 4°C and 25°C, respectively (Fig. 4). The
remaining G protein that bound during the subsequent 10 min of incubation
appeared to occur at a different, and slower rate. Incubation of G protein
and BHK-21 cells for periods longer than 15 min at 4°C and 25°C did not
result in increased binding. A greater amount of G protein bound at 37°C
although this may have been the result, in part, of an internalization of
glycoprotein molecules. In order to minimize this possibility, subsequent
experiments were carried out at 4°C or 25°C.
Several experiments were carried out to assess the possible role of
2+ 2+
Mg and Ca in the binding of G protein to BHK-21 cells. However, increasing
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2+ 2+
the Mg or Ca concentration by 2.5-fold had no measurable effect on
G protein binding and the deletion of these ions from the incubation medium
did not decrease glycoprotein binding (data not shown).
Specificity of G protein binding
The saturable kinetics of G protein binding suggested that the inter-
action of the glycoprotein with the cell surface involved a limited number
of sites that may be specific (Figs. 3 and 4). If this was true the binding
of G protein should have been dependent on cell concentration and an excess
of unlabeled G protein should have competed with the radiolabeled glycoprotein.
Various concentrations of BHK-21 cells were incubated with a saturating
amount of radiolabeled G protein (Table 2). A total of 3.1-3.5 X 10 5 molecules
of G protein bound per cell regardless of the number of cells used. Under
similar incubation conditions calculations from 34 independent determinations
throughout this study showed that 3.3 X 10
5
G protein molecules bound per
BHK-21 cell.
Further evidence for a saturable binding of G protein was obtained by
mixing known concentrations of unlabeled G protein with a constant amount of
radiolabeled G protein. The binding of 0.6 v g of added labeled G protein
was inhibited by unlabeled G protein in a competitive fashion in that the
measured decrease in labeled G protein bound was consistent with that
calculated on the basis of competitive inhibition (Table 3). However, the
calculated and observed G protein binding was only consistent when 1.4 ug
and 2.8 ug of unlabeled G protein was present in the reaction mixtures.
When 0.8 ug of unlabeled G protein was mixed with 0.6 ug of the radiolabeled
glycoprotein, 61% of the labeled protein bound which was well above the 42%
calculated. This indicated that 0.6 ug of G protein was not sufficient to
saturate all cell binding sites and that at least 2.0 ug of G protein was
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sufficient to provide saturation kinetics with 1 X 10 cells. This observa-
tion was consistent with the saturation curve illustrated in Fig. 3. In
addition, this observation eliminated the possibility that the measured
number of G protein molecules bound per cell was appreciably a result of
6 protein aggregation.
Comparison of G protein and VSV binding
Now convinced that the binding of G protein was saturable and involved
5
approximately 3 X 10 sites per cell, we felt that comparisons between the
binding of purified G protein and VSV virions could be made with confidence.
Since Schloemer and Wagner (1975) reported that the infectivity of VSV
could be decreased by the treatment of virions with neuraminidase, we
incubated both the virions and the G protein with neuraminidase as described
in the Methods and measured their subsequent ability to bind to BHK-21 cells.
Neuraminidase treatment resulted in a 1.5 to 2.0 log loss of infectious VSV,
as measured by plaque assay, although virion attachment was reduced by only
25% (data not shown). Treatment of the G protein with neuraminidase also
had little affect on the ability of the isolated glycoprotein to bind
to cell surfaces. Although antibody, directed against the G protein of VSV,
clearly neutralizes viral infectivity (Kelley et al_. , 1972; Dietzschold et al_.
,
1974), it is not known if the antiserum directly inhibits virion attachment
or interferes with later stages of infection. We found that incubation of
VSV or G protein with anti-G IgG sufficient to reduce viral infectivity by
four logs did not decrease either virion or the purified protein binding
to BHK-21 cells (data not shown). These results, therefore, had little
value in discriminating between the attachment properties of the intact VSV
virions and the purified G protein.
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The ability of BHK-21 cells to bind intact VSV virions and isolated G
protein was not diminished by preincubation of the cells with trypsin
(Table 4). However, phospholipase A increased their ability to bind G
protein while the attachment of intact VSV virions was somewhat reduced.
The enhanced binding of G protein by pre-exposure of the cells to phospholipase
A was most likely a reflection of an increased exposure of cell surface
receptors to the glycoprotein. Treatment of BHK-21 cells with phospholipase C
slightly reduced G protein binding although the enzyme had little affect
on the attachment of intact VSV (Table 4). The differences in cellular
binding that resulted from these enzymatic treatments were not of a magnitude
to be unequivocal. Although this was the first evidence that the nature of
the binding of the isolated G protein and the VSV virions was different, a
more direct assessment was necessary.
Competitive binding by the virions and the G protein
Since the binding of radiolabeled G protein was inhibited by unlabeled
G protein (Table 3), a more direct approach was available to compare the
attachment of the glycoprotein and the VSV virions. The presence of a
saturating quantity of G protein did not interfere with the binding of
radiolabeled VSV virions to BHK-21 cells (Table 5). In addition, the
presence of intact virions did not reduce the amount of radiolabeled G
protein that was bound (Table 5). These observations clearly indicated
that the purified glycoprotein, although binding to a saturatable cell
surface component, did not bind in a fashion that was identical to the
intact virion. In support of this conclusion, we also could not find
evidence that the G protein, bound to BHK-21 cells prior to the addition
of VSV, was displaced when virions were added.
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Chemical cross! inking of the G protein to BHK-21 cells
In order to compare the cell surface components that primarily bound
the isolated G protein and the G protein in the intact virion, we cross-
linked the bound molecules with DTBP, an imidoester that reacts with primary
amines and is cleaved by mercaptoethanol
. The G protein or intact VSV virion
was first bound to BHK-21 cells, reacted with DTBP, and the membranes were
then solubilized with NP40 as described in the Methods. The crosslinked
G protein-surface membrane complexes were precipitated with anti-G IgG
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and proteins were iodinated with I. When radiolabeled G protein were
used to measure total recovery by this method, over 65% of the initial
G protein was recovered by precipitation with the antibody. The iodinated
components were finally resolved by two dimensional diagonal electrophoresis
to allow the identification of cell surface moieties that were associated
with the free and virion bound G protein.
In the absence of both G protein and the DTBP crossl inker, only two
cell surface components were found to be linked by disulfide bonds (Fig. 5a,
arrows). Based on their positions in the slab gel and their migration in
the 1st dimension (the crosslinked form), these cell surface components
appeared to naturally exist as homodimers and homotetramers. In the presence
of the DTBP crossl inker, but the absence of either isolated G protein or
VSV virions, a total of six host cell membrane components were found to
migrate at positions out of the diagonal (Fig. 5a). When G protein was
bound to the cells prior to crossl inking with DTBP, ten additional host cell
proteins were found to be crosslinked (Fig. 5b). Of these, only components
1 (79,000 daltons) and 2 (26,000 daltons) appeared to be crosslinked with
the G protein. According to their migration in the 1st dimension as cross-
linked species, the G protein could have been complexed to both cell com-
ponents. For instance, cell surface component 1, crosslinked with the
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G protein, could migrate at 137,000 daltons rather than the accumulative
148,000 daltons, because the G protein itself contains an internal disulfide
bond and will migrate faster in the absence of mercaptoethanol (Mudd &
Swanson, 1978). In a similar fashion, a crosslinked complex of three cell
components 2 and a G protein would migrate at approximately 137,000 daltons
in the 1st dimension.
Although not covalently crosslinked to the G protein by DTBP, cell
components 3, 4, 5 and 6 were crosslinked as a result of the addition of
the glycoprotein (Fig. 5b). Most likely these cell components were originally
complexed with the G protein, and precipitated by the anti-G IgG, although
amine groups of the G protein and these cell components were not situated
properly for DTBP to form a crosslink. This would escape direct analysis
since the presence of SDS would dissociate the G protein from the chemically
crosslinked cell components. These four crosslinked species were not
visualized when intact virions were reacted with the cell surface (Fig. 5c).
In addition to the above four cell components that were crosslinked
when G proteins, but not VSV virions, were added, other differences were
clearly established that explained the inability of the isolated G proteins
and the virions to compete in surface binding. For instance, only cellular
component 2 (26,000 daltons) and not component 1 was crosslinked to the
G protein when intact virions were bound to the cell surface (Fig. 5c).
In addition, cell components 7 and 8, as well as 9 and 10, were crosslinked
when intact virions were used. None of these four cell proteins were
crosslinked when isolated G protein was bound (Fig. 5b).
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DISCUSSION
When VSV virions were solubilized with Np40, the two envelope proteins,
M and G, were found in the soluble fraction. A single separation step using
Sephadex G-75 allowed the recovery of 55% of the virion G protein in a
fraction that was 97% pure. Although Triton X-100 (Kelley et al_. , 1972)
was also used, we did not find that it was as efficient as NP40. The
purified G protein appeared to be intact and to migrate on SDS-PAGE gels
identical to the original virion glycoprotein. The G protein bound
efficiently to BHK-21 cells, at a rapid rate and in a saturable manner,
5
resulting in 3 X 10 molecules bound per cell (Table 2). This was similar
to previous observations involving isolated proteins of murine leukemia
virus (DeLarco & Todaro, 1976), and adenovirus (Philipson et al_. , 1968).
This is in contrast to the unsaturable kinetics measured with myxoviruses
(Lonberg-Holm & Philipson, 1974). The fact that unlabeled G protein
competed with the binding of labeled molecules suggested that there are a
definite number of receptor sites on the cell surface and that the attachment
kinetics did not reflect an aggregation of the glycoprotein molecules (Table
3). This is similar to the report of Weissman et al . (1977) who showed
that the binding of the murine leukemia virus was saturable and not a result
of aggregation. Although the binding of the VSV G protein was more rapid
at 25 C than at 4 C, the total number of molecules bound at 15 min was
very similar (Fig. 4). Longer incubation periods did not lead to more





deletion from the incubation medium, had no affect on G protein binding
to BHK-21 cells. This is in contrast to the cation sensitivity of binding
of the gp71 of murine leukemia virus to isolated membranes of 3T3 cells
(Kalyanaraman e_t a_L , 1978)
.
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Several experiments were carried out to compare the properties of the
binding of the VSV G protein and the intact virion. Treatment of the VSV
glycoprotein with neuraminidase did not reduce its ability to attach to
BHK-21 cells. Although neuraminidase reduced virion infectivity by approxi-
mately 99%, the ability of the virions to attach was only decreased by 25%.
Preincubation of the BHK-21 cells with trypsin did not affect the binding
of the purified G protein or the intact virions. A similar observation
has been reported by Schloemer and Wagner (1975) where trypsinization of
BHK-21 cells actually increased the ability of VSV at attach. Treatment
of cells with phospholipase A and phospholipase C, suggested that the cell
surface components responsible for the binding of the G protein and the
virions may have been different (Table 4). However, the differences were
small compared to the observations of Kalyanaraman et al_. (1978) and,
therefore, difficult to interpret. However, the inability of the G protein
to compete with the binding of the intact virion indicated that there were
independent attachment sites for the glycoprotein and the virion (Table 5).
In a similar fashion, the virion was unable to compete against the binding
of the G protein. Even preadsorption of either the G protein or the VSV
virion did not affect the subsequent binding of the other. No evidence
could be found that the relative affinity of the virion for the cell surface
receptor was greater than that of the purified G protein.
A direct examination of the cell surface moieties responsible for the
binding of the G protein and the intact virion involved the use of a chemical
crossl inker and a purified anti-G IgG preparation. In both cases the
presence of the ligand caused the crossl inking of several cell surface
components (Fig. 5). There were some surface proteins that appeared to
be associated with the binding of both the purified G protein and the intact
virions. More importantly, and consistent with their inability to
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cross-compete for binding, the majority of cell surface components
associated with the attachment of the G protein and the intact virion were
not shared. Evidently, the manner in which the G protein is presented,
when freed from the virion envelope, is quite different than the closely
packed G protein molecules at the virion surface. It is possible that the
clusters of G protein in the virion envelope may have a different
selectivity for all surface receptors than the single G protein molecules.
Perhaps the insertion of the G protein into liposomes would provide a cell
surface probe that would be more similar to the intact virion. In any
event, it is clear from our data that isolated glycoproteins known to be
responsible for viral attachment, must be used with caution as molecular
probes for the identification of surface receptors associated with viral
attachment. This may be particularly important with viruses like VSV
that have a yery broad host range and, perhaps, can attach to a wide
spectrum of host cell surface components. Perhaps this experimental approach
is most appropriate for viruses that have a highly restricted host range and,
therefore, interact with a limited number of cell surface components (Neurath
et aj_.
,
1970; DeLarco & Todaro, 1976; Kalyanaraman et a].., 1978).
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Fig. l. Separation of viral proteins by SDS-PAGE. VSV was isolated from
infected BHK-21 cells and isolated as described in the text. The viral
proteins were then separated by electrophoresis on an SDS-polyacryl amide
gel, stained with Coomassie blue, destained with 10% acetic acid, and scanned
at 550nm using a Gilford linear transport scanner (solid line). In
a separate experiment, H-fucose was added to the infected BHK-21 cells
in order to radioactively label newly-synthesized VSV. Following virus
isolation and electrophoresis, the polyacryl amide gel was sliced into 1 mm
slices. The slices were dissolved in an NCS solution and the radioactivity
(broker line) in each slice was determined as described in the text.




Fig. 2. Analysis of isolated G protein by SDS-PAGE. The M and G
envelope proteins, which were solubilized by extraction with NP40, were
separated by Sephadex G-75 gel filtration. The void volume fraction,
which appeared to contain almost solely the G glycoprotein, were
separated by gel electrophoresis, stained with Coomassie blue and scanned
at 550nm. The M protein was detected in fractions eluting after the


































Table 1. FRACTIONATION OF THE VSV PROTEINS
Viral protein









L 3.2 + 0.5 100.0 + 0.0
N 33.7 + 1.8 96.4 + 1.2 3.6 + 1.2
G 28.5 + 1.5 25.3 + 2.8 74.7 + 2.9
M 34.6 + 1.3 43.8 + 5.3 56.2 + 5.2
* The VSV proteins were separated by SDS-PAGE, stained with Coomassie
blue, and the gels were scanned at 550nm as in Fig.l. The area under
each protein peak was integrated to determine the % each VSV protein
was of the total virion protein content.
f The VSV virions were dissociated by NP40 treatment, followed by
centrifugation into a nucleocapsid pellet and soluble fraction as
described in the text. The % of each protein present in each
fraction was determined from SDS-PAGE analysis of the fractions.
All values represent the mean of 5 to 8 independent experiments +
S.E.M.
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10.0 31.4 3.1 + 0.2
7.5 26.6 3.5 + 0.3
5.0 16.2 3.2 + 0.1
Different concentrations of BHK-21 cells were incubated with a
saturating amount of radiolabeled G protein at 25°C for 30 min.
Radioactivity which remained associated with washed BHK-21 cells was
evaluated and the number of G protein molecules bound per cell was
calculated from the specific activity of the G protein.
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Table 3. COMPETITIVE INHIBITION OF BINDING OF RADIOLABELED G PROTEIN
BY UNLABELED G PROTEIN
Calculated Observed
binding' binding?











0.8 7.70 X 10
4
1.4 3.10 X 104









* Radiolabeled G protein (0.6/^g) was added to various concentrations
of unlabeled G protein to 1 X 107 BHK-21 cells for 30 min at 25°C.
The number of radiolabeled G protein molecules bound was determined
from duplicate samples as described in the Methods.
\ The calculated or expected binding was determined from the amount of
G protein which should be bound to BHK-21 cells if the binding was
saturable and if unlabeled G protein could competitively inhibit labeled
G protein binding.
+ The observed percentages of G protein binding were calculated from the
amount bound compared to that bound in the controls with no unlabeled
G protein added.
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Table 4. EFFECTS OF ENZYME TREATMENT OF HOST CELLS ON ATTACHMENT







trypsin G protein 107
VSV 92
phospholipase A G protein 136
VSV 80
phospholipase C G protein 81
VSV 106
X 100
* Approximately 7.5 X 10 BHK-21 cells were treated with the various
enzyme treatments as described in the Methods. Saturating amounts of
G protein (8/Ag) or 4,000 CPM of radiolabeled VSV were added to the
treated cells and binding was determined relative to binding to
untreated cells. The values presented are the average of duplicate
measurements.
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Table 5. EFFECTS ON THE BINDING OF G PROTEIN AND THE WHOLE VIRION WITH
THE ADDITION OF UNLABELED VIRIONS OR G PROTEIN, RESPECTIVELY
Experiment 1. -Competitive inhibition of viral attachment with
G protein *

























* 3,000 CPM of whole VSV virions, mixed with various amounts of
unlabeled G protein, were added to 7.5 X 10
6
BHK-21 cells and
incubated at 25°C for 30 min. The radioactivity which remained with
the washed cells was determined and compared to the amount of VSV
which bound in the absence of G protein. Values represent the
average of four measurements.
| Saturating amounts of radiolabeled G protein (9/<g) were mixed with
various amounts of unlabeled VSV prior to the addition to 7.5 X 10
BHK-21 cells. The number of G protein molecules bound was evaluated
after 30 min incubation at 25°C. Values represent the average of four
measurements.
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•The glycoprotein (G) of vesicular stomatitis virus was radiolabeled,
extracted and purified to allow the study of its potential interaction with
host cell surfaces. Incubation of BHK-21 cells with the radiolabeled viral
glycoprotein resulted in a rapid attachment of the viral component to the
cell surface. The- attachment was shown to be temperature dependent and
5
saturable in that approximately 3 X 10 molecules bound per cell. The
++ ++
deletion of Mg or Ca from the incubation medium had little affect on
the glycoprotein binding. Treatment of the isolated G protein and intact
virions with neuraminidase did not significantly decrease their binding
to BHK-21 cells. Preincubation of cells with trypsin did not decrease the
attachment of VSV virions nor the binding of purified G protein. Treatment
of cells with phospholipase A or phosphol ipase C suggested that the binding
of the glycoprotein and the intact virion may have been dissimilar. Unlabeled
glycoprotein was shown to competitively inhibit binding of the labeled
molecules although the presence of intact virions did not inhibit attach-
ment of the G protein. Likewise, saturating amounts of the glycoprotein
did not decrease binding of vesicular stomatitis virus to BHK-21 cells.
These observations suggested that the isolated glycoprotein either bound
to cell surface components that were distinct from the virion receptor or
that the manner of the purified glycoprotein attachment was different than
the G protein still associated with the intact virion. Chemical cross-
linking and diagonal two-dimensional gel electrophoresis were used to
identify and to compare the cell surface components responsible for glyco-
protein and virion attachment.
